The use of chasteberry extract (vitex agnus castus) in gynecology;Extrakte aus mönchspfeffer (vitex agnus castus). Stellenwert der therapie in der gynäkologischen praxis

Gynakologische Endokrinologie

Volumn 6, Issue 2, 2008, Pages 82-86

  Wuttke, W ^a   Jarry, H ^a   Seidlova Wuttke D ^a   Devyatchenko, T ^b   Pogodin, O ^c   Levenets, S A ^d  

^a UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^b VOLGOGRAD STATE MEDICAL UNIVERSITY   (Russian Federation)

^c PETROZAVODSK STATE UNIVERSITY   (Russian Federation)

^d Academy of Medical Sciences Khakov   (Russian Federation)

Author keywords

Agnus castus; Chasteberry extract; Corpus luteum deficiency; Premenstrual mastodynia; Prolactin

Indexed keywords

AGNUCASTON; BROMOCRIPTINE; DITERPENE; DOPAMINE 2 RECEPTOR STIMULATING AGENT; MASTODYNON; PLACEBO; VITEX AGNUS CASTUS EXTRACT;

ARTICLE; CLINICAL TRIAL; DOPAMINERGIC ACTIVITY; GYNECOLOGY; HUMAN; HYPERPROLACTINEMIA; LUTEAL INSUFFICIENCY; MASTALGIA; VITEX AGNUS CASTUS;

EID: 44149126917     PISSN: 16102894     EISSN: 16102908     Source Type: Journal    
DOI: 10.1007/s10304-008-0262-9     Document Type: Article

References (20)

1. Breckwoldt M (1990) Endocrinology and therapy of breast diseases. Zentralbl Gynakol 112: 1097-1099
2. Castillo E, Garibay M, Mirabent F (2006) Effect of alpha dihydroergocryptine in patients with fibrocystic breast disease. Ginecol Obstet Mex 74: 580-584
3. Daniele C, Thompson Coon J et al. (2005) Vitex agnus castus: a systematic review of adverse events. Drug Saf 28: 319-332
4. Dogliotti L, Mansel RE (1989) Bromocriptine treatment of cyclical mastalgia/fibrocystic breast disease: update on the European trial. Br J Clin Pract Suppl 68: 26-32; discussion 49-53
5. Gerhard II, Patek A, Monga B et al. (1998) Mastodynon(R) bei weiblicher Sterilitat. Forsch Komplementarmed 5: 272-278
6. Halaska M, Raus K, Beles P et al. (1998) Treatment of cyclical mastodynia using an extract of Vitex agnus castus: results of a double-blind comparison with a placebo. Ceska Gynekol 63: 388-392
7. Jarry EAH (2006) In vitro assays for bioactivity-guided isolation of endocrine active compounds in vitex agnus-castus. Maturitas 55S: 26-36
8. Jarry H, Leonhardt S, Gorkow C, Wuttke W (1994) In vitro prolactin but not LH and FSH release is inhibited by compounds in extracts of Agnus castus: direct evidence for a dopaminergic principle by the dopamine receptor assay. Exp Clin Endocrinol 102: 448-454
9. Kubista E, Muller G, Spona J (1987) Treatment of mastopathies with cyclic mastodynia. Clinical results and hormonal profiles. Rev Fr Gynecol Obstet 82: 221-227
10. Meier B, Berger D, Hoberg E et al. (2000) Pharmacological activities of Vitex agnus-castus extracts in vitro. Phytomedicine 7: 373-381
11. Milewicz A, Gejdel E, Sworen H et al. (1993) Vitex agnus castus extract in the treatment of luteal phase defects due to latent hyperprolactinemia. Results of a randomized placebo-controlled double-blind study. Arzneimittelforschung 43: 752-756
12. Murta EF, de Freitas MM, Velludo MA (1992) Histologic changes in fibrocystic breast disease before and after treatment with bromocriptine. Rev Paul Med 110: 251-256
13. Nazli K, Syed S, Mahmood MR, Ansari F (1989) Controlled trial of the prolactin inhibitor bromocriptine (Parlodel) in the treatment of severe cyclical mastalgia. Br J Clin Pract 43: 322-327
14. Prilepskaya EAVN (2006) Vitex agnus castus: successful treatment of moderate to severe premenstrual syndrome. Maturitas 55S: 55-63
15. Schwibbe M, Becker D, Wuttke W (1983) EEG and psycho-logical effects of lisuride in women with premenstrueal tension. In: Calne DB, Horowski R, McDonald RJ, Wuttke W (eds) Lisurides and other dopamine agonists, Raven Press, New York, pp 345-355
16. Suginami H, Ito T, Hamada K et al. (1986) Serum prolactin levels during sleep and in metoclopramide stimulation in normoprolactinemic anovulation and ovulation induction with bromocriptine. Nippon Sanka Fujinka Gakkai Zasshi 38: 728-734
17. Vizoso F, Allende MT, Garcia-Muniz JL et al. (1992) Serum prolactin levels in women with gross cystic breast disease. Int J Biol Markers 7: 225-229
18. Wang DY, Fentiman IS (1985) Epidemiology and endocrinology of benign breast disease. Breast Cancer Res Treat 6: 5-36
19. Winterhoff HG, Behr C (1991) Die Hemmung der Laktation bei Ratten als indirekter Beweis für die Senkung von Prolaktin durch Agnus castus. Z Phytotherapie 12: 175-179
20. Wuttke W, Jarry H, Christoffel V et al. (2003) Chaste tree (Vitex agnus-castus) - pharmacology and clinical indications. Phytomedicine 10: 348-357